Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder

Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder

Abstract In Thailand, resource limitations lead many multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients to use off-label immunosuppressants. This study assesses the efficacy and safety of rituximab (RTX) with a CD19-based reinfusion regimen among Thai MS and NMOSD pa...

Full description

Bibliographic Details
Main Authors: Tatchaporn Ongphichetmetha, Jiraporn Jitprapaikulsan, Sasitorn Siritho, Natthapon Rattanathamsakul, Thammachet Detweeratham, Naraporn Prayoonwiwat
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-53838-y

Similar Items

Similar Items